
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11547292
[patent_doc_number] => 09616114
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-04-11
[patent_title] => 'Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity'
[patent_app_type] => utility
[patent_app_number] => 14/858810
[patent_app_country] => US
[patent_app_date] => 2015-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 20571
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14858810
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/858810 | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity | Sep 17, 2015 | Issued |
Array
(
[id] => 10727491
[patent_doc_number] => 20160073640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND ANOTHER BIOLOGICAL CONTROL AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/857176
[patent_app_country] => US
[patent_app_date] => 2015-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 32551
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14857176
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/857176 | Compositions comprising recombinant | Sep 16, 2015 | Issued |
Array
(
[id] => 11684079
[patent_doc_number] => 09682110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Antibacterial phage, phage peptides and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/852112
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 228
[patent_figures_cnt] => 230
[patent_no_of_words] => 24966
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14852112
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/852112 | Antibacterial phage, phage peptides and methods of use thereof | Sep 10, 2015 | Issued |
Array
(
[id] => 14653555
[patent_doc_number] => 20190233906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => MUTANT STRAINS OF STAPHYLOCOCCUS AUREUS WITH MULTIPLE INACTIVATED TCS SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 15/755531
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755531
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755531 | MUTANT STRAINS OF STAPHYLOCOCCUS AUREUS WITH MULTIPLE INACTIVATED TCS SYSTEMS | Aug 25, 2015 | Abandoned |
Array
(
[id] => 11297815
[patent_doc_number] => 09505810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Toxins in type A Clostridium perfringens'
[patent_app_type] => utility
[patent_app_number] => 14/832647
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 7
[patent_no_of_words] => 23945
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832647
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/832647 | Toxins in type A Clostridium perfringens | Aug 20, 2015 | Issued |
Array
(
[id] => 10812177
[patent_doc_number] => 20160158337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'CHLAMYDIA ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/831535
[patent_app_country] => US
[patent_app_date] => 2015-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 35769
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14831535
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/831535 | Chlamydia antigens | Aug 19, 2015 | Issued |
Array
(
[id] => 10670876
[patent_doc_number] => 20160017022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'Methods to Protect Against and Treat Multiple Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 14/826476
[patent_app_country] => US
[patent_app_date] => 2015-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 29069
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14826476
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/826476 | Methods to protect against and treat multiple sclerosis | Aug 13, 2015 | Issued |
Array
(
[id] => 10728343
[patent_doc_number] => 20160074492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'Oral Vaccine For Borrelia'
[patent_app_type] => utility
[patent_app_number] => 14/819984
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22212
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14819984
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/819984 | Oral Vaccine For Borrelia | Aug 5, 2015 | Abandoned |
Array
(
[id] => 14168125
[patent_doc_number] => 10258048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 14/814122
[patent_app_country] => US
[patent_app_date] => 2015-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 14068
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14814122
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/814122 | None | Jul 29, 2015 | Issued |
Array
(
[id] => 11210917
[patent_doc_number] => 09439934
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-09-13
[patent_title] => 'Application of an attenuated salmonella typhimurium, its genetically engineered bacterium in preparing drugs for the treatment of prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 14/813338
[patent_app_country] => US
[patent_app_date] => 2015-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 3467
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14813338
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/813338 | Application of an attenuated salmonella typhimurium, its genetically engineered bacterium in preparing drugs for the treatment of prostate cancer | Jul 29, 2015 | Issued |
Array
(
[id] => 11357379
[patent_doc_number] => 09534022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus '
[patent_app_type] => utility
[patent_app_number] => 14/802602
[patent_app_country] => US
[patent_app_date] => 2015-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22308
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14802602
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/802602 | Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus | Jul 16, 2015 | Issued |
Array
(
[id] => 11773465
[patent_doc_number] => 09382302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Lutzomyia longipalpis polypeptides and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/802168
[patent_app_country] => US
[patent_app_date] => 2015-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 28805
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14802168
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/802168 | Lutzomyia longipalpis polypeptides and methods of use | Jul 16, 2015 | Issued |
Array
(
[id] => 11224502
[patent_doc_number] => 09452213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity'
[patent_app_type] => utility
[patent_app_number] => 14/800126
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2779
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800126
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/800126 | Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity | Jul 14, 2015 | Issued |
Array
(
[id] => 12930910
[patent_doc_number] => 09829490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Use of amino acid sequences from
[patent_app_type] => utility
[patent_app_number] => 14/798241
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 9727
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798241
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/798241 | Use of amino acid sequences from | Jul 12, 2015 | Issued |
Array
(
[id] => 10483288
[patent_doc_number] => 20150368304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A AND B'
[patent_app_type] => utility
[patent_app_number] => 14/751790
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 95
[patent_no_of_words] => 47729
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14751790
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/751790 | Nucleic acids and proteins from Streptococcus groups A and B | Jun 25, 2015 | Issued |
Array
(
[id] => 10389806
[patent_doc_number] => 20150274814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/736751
[patent_app_country] => US
[patent_app_date] => 2015-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14569
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14736751
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/736751 | Methods of treating and preventing Staphylococcus aureus infections and associated conditions | Jun 10, 2015 | Issued |
Array
(
[id] => 15338871
[patent_doc_number] => 10525092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Compositions and methods for preventing infections
[patent_app_type] => utility
[patent_app_number] => 15/317603
[patent_app_country] => US
[patent_app_date] => 2015-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3036
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317603
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317603 | Compositions and methods for preventing infections | Jun 10, 2015 | Issued |
Array
(
[id] => 11184780
[patent_doc_number] => 09416172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-16
[patent_title] => 'Compositions and methods for treating and preventing Staphylococcus aureus infections'
[patent_app_type] => utility
[patent_app_number] => 14/729260
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 11969
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729260
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729260 | Compositions and methods for treating and preventing Staphylococcus aureus infections | Jun 2, 2015 | Issued |
Array
(
[id] => 10365837
[patent_doc_number] => 20150250842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'COMBINATION AND/OR COMPOSITION COMPRISING BACILLUS, AND YUCCA, QUILLAJA, OR BOTH AND A METHOD FOR USING AND MAKING'
[patent_app_type] => utility
[patent_app_number] => 14/699740
[patent_app_country] => US
[patent_app_date] => 2015-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 9594
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699740
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/699740 | Combination and/or composition comprising bacillus, and yucca, quillaja, or both and a method for using and making | Apr 28, 2015 | Issued |
Array
(
[id] => 11342388
[patent_doc_number] => 09526774
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-12-27
[patent_title] => 'Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus '
[patent_app_type] => utility
[patent_app_number] => 14/690889
[patent_app_country] => US
[patent_app_date] => 2015-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7764
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14690889
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/690889 | Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus | Apr 19, 2015 | Issued |